Global Preimplantation Genetic Diagnosis (PGD) Market Growth (Status and Outlook) 2021-2026


Jun, 2021 | Report ID: 181745 | 132 | Pharmaceuticals and Healthcare

According to this latest study, the 2021 growth of Preimplantation Genetic Diagnosis (PGD) will have significant change from previous year. By the most conservative estimates of global Preimplantation Genetic Diagnosis (PGD) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Preimplantation Genetic Diagnosis (PGD) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Preimplantation Genetic Diagnosis (PGD) market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

Chromosomal Abnormalities

Gender Selection

X-linked Diseases

Aneuploidy

Single Gene Disorders

Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

Maternity Centers & Fertility Clinics

Hospitals, Diagnostic Labs, and Service Providers

Research Laboratories & Academic Institutes

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Illumina

Thermo Fisher

Agilent Technologies

PerkinElmer

Coopersurgical

Abbott Laboratories

Natera

Takara Bio

Oxford Gene Technology

Yikon Genomics

Progenesis

Beijing Genomics Institute

Invitae

Invicta Genetics

Combimatrix

Genea Limited

Bioarray

Quest Diagnostics


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size 2016-2026

2.1.2 Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Preimplantation Genetic Diagnosis (PGD) Segment by Type

2.2.1 Chromosomal Abnormalities

2.2.2 Chromosomal Abnormalities

2.2.3 X-linked Diseases

2.2.4 Aneuploidy

2.2.5 Single Gene Disorders

2.2.6 Others

2.3 Preimplantation Genetic Diagnosis (PGD) Market Size by Type

2.3.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Type

2.3.2 Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2016-2021)

2.4 Preimplantation Genetic Diagnosis (PGD) Segment by Application

2.4.1 Maternity Centers & Fertility Clinics

2.4.2 Hospitals, Diagnostic Labs, and Service Providers

2.4.3 Research Laboratories & Academic Institutes

2.5 Preimplantation Genetic Diagnosis (PGD) Market Size by Application

2.5.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Application

2.5.2 Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2016-2021)

3 Preimplantation Genetic Diagnosis (PGD) Market Size by Players

3.1 Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Players

3.1.1 Global Preimplantation Genetic Diagnosis (PGD) Revenue by Players (2019-2021E)

3.1.2 Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2019-2021E)

3.2 Global Preimplantation Genetic Diagnosis (PGD) Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Preimplantation Genetic Diagnosis (PGD) by Regions

4.1 Preimplantation Genetic Diagnosis (PGD) Market Size by Regions (2016-2021)

4.2 Americas Preimplantation Genetic Diagnosis (PGD) Market Size Growth (2016-2021)

4.3 APAC Preimplantation Genetic Diagnosis (PGD) Market Size Growth (2016-2021)

4.4 Europe Preimplantation Genetic Diagnosis (PGD) Market Size Growth (2016-2021)

4.5 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Growth (2016-2021)

5 Americas

5.1 Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)

5.2 Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)

5.3 Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2016-2021)

6.2 APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)

6.3 APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Preimplantation Genetic Diagnosis (PGD) by Country (2016-2021)

7.2 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)

7.3 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) by Region (2016-2021)

8.2 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)

8.3 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.1 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Regions (2021-2026)

10.1.1 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Regions (2021-2026)

10.1.2 Americas Preimplantation Genetic Diagnosis (PGD) Forecast

10.1.3 APAC Preimplantation Genetic Diagnosis (PGD) Forecast

10.1.4 Europe Preimplantation Genetic Diagnosis (PGD) Forecast

10.1.5 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Forecast

10.2 Americas Preimplantation Genetic Diagnosis (PGD) Forecast by Countries (2021-2026)

10.2.1 United States Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.2.2 Canada Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.2.3 Mexico Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.2.4 Brazil Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.3 APAC Preimplantation Genetic Diagnosis (PGD) Forecast by Region (2021-2026)

10.3.1 China Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.3.2 Japan Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.3.3 Korea Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.3.4 Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.3.5 India Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.3.6 Australia Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.4 Europe Preimplantation Genetic Diagnosis (PGD) Forecast by Country (2021-2026)

10.4.1 Germany Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.4.2 France Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.4.3 UK Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.4.4 Italy Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.4.5 Russia Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.5 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Forecast by Region (2021-2026)

10.5.1 Egypt Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.5.2 South Africa Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.5.3 Israel Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.5.4 Turkey Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.5.5 GCC Countries Preimplantation Genetic Diagnosis (PGD) Market Forecast

10.6 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Type (2021-2026)

10.8 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Illumina

11.1.1 Illumina Company Information

11.1.2 Illumina Preimplantation Genetic Diagnosis (PGD) Product Offered

11.1.3 Illumina Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Illumina Main Business Overview

11.1.5 Illumina Latest Developments

11.2 Thermo Fisher

11.2.1 Thermo Fisher Company Information

11.2.2 Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Product Offered

11.2.3 Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 Thermo Fisher Main Business Overview

11.2.5 Thermo Fisher Latest Developments

11.3 Agilent Technologies

11.3.1 Agilent Technologies Company Information

11.3.2 Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Product Offered

11.3.3 Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Agilent Technologies Main Business Overview

11.3.5 Agilent Technologies Latest Developments

11.4 PerkinElmer

11.4.1 PerkinElmer Company Information

11.4.2 PerkinElmer Preimplantation Genetic Diagnosis (PGD) Product Offered

11.4.3 PerkinElmer Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 PerkinElmer Main Business Overview

11.4.5 PerkinElmer Latest Developments

11.5 Coopersurgical

11.5.1 Coopersurgical Company Information

11.5.2 Coopersurgical Preimplantation Genetic Diagnosis (PGD) Product Offered

11.5.3 Coopersurgical Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 Coopersurgical Main Business Overview

11.5.5 Coopersurgical Latest Developments

11.6 Abbott Laboratories

11.6.1 Abbott Laboratories Company Information

11.6.2 Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Product Offered

11.6.3 Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Abbott Laboratories Main Business Overview

11.6.5 Abbott Laboratories Latest Developments

11.7 Natera

11.7.1 Natera Company Information

11.7.2 Natera Preimplantation Genetic Diagnosis (PGD) Product Offered

11.7.3 Natera Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 Natera Main Business Overview

11.7.5 Natera Latest Developments

11.8 Takara Bio

11.8.1 Takara Bio Company Information

11.8.2 Takara Bio Preimplantation Genetic Diagnosis (PGD) Product Offered

11.8.3 Takara Bio Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Takara Bio Main Business Overview

11.8.5 Takara Bio Latest Developments

11.9 Oxford Gene Technology

11.9.1 Oxford Gene Technology Company Information

11.9.2 Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Product Offered

11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Oxford Gene Technology Main Business Overview

11.9.5 Oxford Gene Technology Latest Developments

11.10 Yikon Genomics

11.10.1 Yikon Genomics Company Information

11.10.2 Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Product Offered

11.10.3 Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Yikon Genomics Main Business Overview

11.10.5 Yikon Genomics Latest Developments

11. Progenesis

11.11.1 Progenesis Company Information

11.11.2 Progenesis Preimplantation Genetic Diagnosis (PGD) Product Offered

11.11.3 Progenesis Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Progenesis Main Business Overview

11.11.5 Progenesis Latest Developments

11.12 Beijing Genomics Institute

11.12.1 Beijing Genomics Institute Company Information

11.12.2 Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Product Offered

11.12.3 Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 Beijing Genomics Institute Main Business Overview

11.12.5 Beijing Genomics Institute Latest Developments

11.13 Invitae

11.13.1 Invitae Company Information

11.13.2 Invitae Preimplantation Genetic Diagnosis (PGD) Product Offered

11.13.3 Invitae Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.13.4 Invitae Main Business Overview

11.13.5 Invitae Latest Developments

11.14 Invicta Genetics

11.14.1 Invicta Genetics Company Information

11.14.2 Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Product Offered

11.14.3 Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.14.4 Invicta Genetics Main Business Overview

11.14.5 Invicta Genetics Latest Developments

11.15 Combimatrix

11.15.1 Combimatrix Company Information

11.15.2 Combimatrix Preimplantation Genetic Diagnosis (PGD) Product Offered

11.15.3 Combimatrix Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.15.4 Combimatrix Main Business Overview

11.15.5 Combimatrix Latest Developments

11.16 Genea Limited

11.16.1 Genea Limited Company Information

11.16.2 Genea Limited Preimplantation Genetic Diagnosis (PGD) Product Offered

11.16.3 Genea Limited Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.16.4 Genea Limited Main Business Overview

11.16.5 Genea Limited Latest Developments

11.17 Bioarray

11.17.1 Bioarray Company Information

11.17.2 Bioarray Preimplantation Genetic Diagnosis (PGD) Product Offered

11.17.3 Bioarray Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.17.4 Bioarray Main Business Overview

11.17.5 Bioarray Latest Developments

11.18 Quest Diagnostics

11.18.1 Quest Diagnostics Company Information

11.18.2 Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Product Offered

11.18.3 Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2021)

11.18.4 Quest Diagnostics Main Business Overview

11.18.5 Quest Diagnostics Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Chromosomal Abnormalities

Table 3. Major Players of Gender Selection

Table 4. Major Players of X-linked Diseases

Table 5. Major Players of Aneuploidy

Table 6. Major Players of Single Gene Disorders

Table 7. Major Players of Others

Table 8. Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 9. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) & ($ Millions)

Table 10. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2016-2021)

Table 11. Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 12. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) & ($ Millions)

Table 13. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2016-2021)

Table 14. Global Preimplantation Genetic Diagnosis (PGD) Revenue by Players (2019-2021E) & ($ Millions)

Table 15. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2019-2021E)

Table 16. Preimplantation Genetic Diagnosis (PGD) Key Players Head office and Products Offered

Table 17. Preimplantation Genetic Diagnosis (PGD) Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 18. New Products and Potential Entrants

Table 19. Mergers & Acquisitions, Expansion

Table 20. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Regions 2016-2021 & ($ Millions)

Table 21. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Regions 2016-2021

Table 22. Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & ($ Millions)

Table 23. Americas Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Country (2016-2021)

Table 24. Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) & ($ Millions)

Table 25. Americas Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2016-2021)

Table 26. Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) & ($ Millions)

Table 27. Americas Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2016-2021)

Table 28. APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2016-2021) & ($ Millions)

Table 29. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Region (2016-2021)

Table 30. APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) & ($ Millions)

Table 31. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2016-2021)

Table 32. APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) & ($ Millions)

Table 33. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2016-2021)

Table 34. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & ($ Millions)

Table 35. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Country (2016-2021)

Table 36. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) & ($ Millions)

Table 37. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2016-2021)

Table 38. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) & ($ Millions)

Table 39. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2016-2021)

Table 40. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Region (2016-2021)

Table 42. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) & ($ Millions)

Table 43. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2016-2021)

Table 44. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) & ($ Millions)

Table 45. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2016-2021)

Table 46. Key and Potential Regions of Preimplantation Genetic Diagnosis (PGD)

Table 47. Key Application and Potential Industries of Preimplantation Genetic Diagnosis (PGD)

Table 48. Key Challenges of Preimplantation Genetic Diagnosis (PGD)

Table 49. Key Trends of Preimplantation Genetic Diagnosis (PGD)

Table 50. Global Preimplantation Genetic Diagnosis (PGD) Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 51. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Regions (2021-2026)

Table 52. Global Preimplantation Genetic Diagnosis (PGD) Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 53. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Type (2021-2026)

Table 54. Global Preimplantation Genetic Diagnosis (PGD) Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 55. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Application (2021-2026)

Table 56. Illumina Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 57. Illumina Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 58. Illumina Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 59. Illumina Main Business

Table 60. Illumina Latest Developments

Table 61. Thermo Fisher Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 62. Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 63. Thermo Fisher Main Business

Table 64. Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 65. Thermo Fisher Latest Developments

Table 66. Agilent Technologies Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 67. Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 68. Agilent Technologies Main Business

Table 69. Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 70. Agilent Technologies Latest Developments

Table 71. PerkinElmer Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 72. PerkinElmer Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 73. PerkinElmer Main Business

Table 74. PerkinElmer Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 75. PerkinElmer Latest Developments

Table 76. Coopersurgical Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 77. Coopersurgical Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 78. Coopersurgical Main Business

Table 79. Coopersurgical Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 80. Coopersurgical Latest Developments

Table 81. Abbott Laboratories Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 82. Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 83. Abbott Laboratories Main Business

Table 84. Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 85. Abbott Laboratories Latest Developments

Table 86. Natera Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 87. Natera Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 88. Natera Main Business

Table 89. Natera Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 90. Natera Latest Developments

Table 91. Takara Bio Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 92. Takara Bio Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 93. Takara Bio Main Business

Table 94. Takara Bio Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 95. Takara Bio Latest Developments

Table 96. Oxford Gene Technology Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 97. Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 98. Oxford Gene Technology Main Business

Table 99. Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 100. Oxford Gene Technology Latest Developments

Table 101. Yikon Genomics Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 102. Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 103. Yikon Genomics Main Business

Table 104. Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 105. Yikon Genomics Latest Developments

Table 106. Progenesis Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 107. Progenesis Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 108. Progenesis Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 109. Progenesis Main Business

Table 110. Progenesis Latest Developments

Table 111. Beijing Genomics Institute Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 112. Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 113. Beijing Genomics Institute Main Business

Table 114. Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 115. Beijing Genomics Institute Latest Developments

Table 116. Invitae Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 117. Invitae Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 118. Invitae Main Business

Table 119. Invitae Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 120. Invitae Latest Developments

Table 121. Invicta Genetics Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 122. Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 123. Invicta Genetics Main Business

Table 124. Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 125. Invicta Genetics Latest Developments

Table 126. Combimatrix Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 127. Combimatrix Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 128. Combimatrix Main Business

Table 129. Combimatrix Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 130. Combimatrix Latest Developments

Table 131. Genea Limited Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 132. Genea Limited Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 133. Genea Limited Main Business

Table 134. Genea Limited Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 135. Genea Limited Latest Developments

Table 136. Bioarray Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 137. Bioarray Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 138. Bioarray Main Business

Table 139. Bioarray Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 140. Bioarray Latest Developments

Table 141. Quest Diagnostics Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors

Table 142. Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Product Offered

Table 143. Quest Diagnostics Main Business

Table 144. Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 145. Quest Diagnostics Latest Developments

List of Figures

Figure 1. Preimplantation Genetic Diagnosis (PGD) Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type in 2020

Figure 7. Preimplantation Genetic Diagnosis (PGD) in Maternity Centers & Fertility Clinics

Figure 8. Global Preimplantation Genetic Diagnosis (PGD) Market: Maternity Centers & Fertility Clinics (2016-2021) & ($ Millions)

Figure 9. Preimplantation Genetic Diagnosis (PGD) in Hospitals, Diagnostic Labs, and Service Providers

Figure 10. Global Preimplantation Genetic Diagnosis (PGD) Market: Hospitals, Diagnostic Labs, and Service Providers (2016-2021) & ($ Millions)

Figure 11. Preimplantation Genetic Diagnosis (PGD) in Research Laboratories & Academic Institutes

Figure 12. Global Preimplantation Genetic Diagnosis (PGD) Market: Research Laboratories & Academic Institutes (2016-2021) & ($ Millions)

Figure 13. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2020

Figure 14. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Player in 2020

Figure 15. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Regions (2016-2021)

Figure 16. Americas Preimplantation Genetic Diagnosis (PGD) Market Size 2016-2021 ($ Millions)

Figure 17. APAC Preimplantation Genetic Diagnosis (PGD) Market Size 2016-2021 ($ Millions)

Figure 18. Europe Preimplantation Genetic Diagnosis (PGD) Market Size 2016-2021 ($ Millions)

Figure 19. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size 2016-2021 ($ Millions)

Figure 20. Americas Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Country in 2020

Figure 21. Americas Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type in 2020

Figure 22. Americas Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2020

Figure 23. United States Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 24. Canada Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 25. Mexico Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 26. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Regions in 2020

Figure 27. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type in 2020

Figure 28. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2020

Figure 29. China Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 30. Japan Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 31. Korea Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 32. Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 33. India Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 34. Australia Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 35. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Country in 2020

Figure 36. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type in 2020

Figure 37. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2020

Figure 38. Germany Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 39. France Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 40. UK Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 41. Italy Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 42. Russia Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 43. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Region in 2020

Figure 44. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type in 2020

Figure 45. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2020

Figure 46. Egypt Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 47. South Africa Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 48. Israel Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 49. Turkey Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 50. GCC Country Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2016-2021 ($ Millions)

Figure 51. Americas Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 52. APAC Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 53. Europe Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 54. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 55. United States Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 56. Canada Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 57. Mexico Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 58. Brazil Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 59. China Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 60. Japan Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 61. Korea Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 62. Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 63. India Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 64. Australia Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 65. Germany Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 66. France Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 67. UK Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 68. Italy Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 69. Russia Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 70. Spain Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 71. Egypt Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 72. South Africa Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 73. Israel Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 74. Turkey Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Figure 75. GCC Country Preimplantation Genetic Diagnosis (PGD) Market Size 2021-2026 ($ Millions)

Sample Request is not available